Multiple roles for the cytoskeleton in ALS

Exp Neurol. 2022 Sep:355:114143. doi: 10.1016/j.expneurol.2022.114143. Epub 2022 Jun 14.

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease caused by more than sixty genes identified through classic linkage analysis and new sequencing methods. Yet no clear mechanism of onset, cure, or effective treatment is known. Popular discourse classifies the proteins encoded from ALS-related genes into four disrupted processes: proteostasis, mitochondrial function and ROS, nucleic acid regulation, and cytoskeletal dynamics. Surprisingly, the mechanisms detailing the contribution of the neuronal cytoskeletal in ALS are the least explored, despite involvement in these cell processes. Eight genes directly regulate properties of cytoskeleton function and are essential for the health and survival of motor neurons, including: TUBA4A, SPAST, KIF5A, DCTN1, NF, PRPH, ALS2, and PFN1. Here we review the properties and studies exploring the contribution of each of these genes to ALS.

Keywords: Actin; Amyotrophic lateral sclerosis (ALS); Cytoskeleton; Microtubules.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis* / genetics
  • Amyotrophic Lateral Sclerosis* / metabolism
  • Cytoskeleton / metabolism
  • Humans
  • Kinesins
  • Microtubules / metabolism
  • Motor Neurons / metabolism
  • Neurodegenerative Diseases* / metabolism
  • Profilins / genetics
  • Profilins / metabolism
  • Spastin / metabolism

Substances

  • KIF5A protein, human
  • PFN1 protein, human
  • Profilins
  • Spastin
  • Kinesins
  • SPAST protein, human